ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 328410 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 328410; 2) Community: the network communities that were significantly associated with the response to NSC 328410; 3) Molecule: the relationships between components within communities and NSC 328410; 4) MDR: the compounds that were significantly associated with the NSC 328410.

NSC Compound Enrichment Correlation
NSC 602617 Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 0.0297837393005855 0.022154194
NSC 642968 Benzo[g]quinoline-5,10-dione, 5,10-dihydro- 4-[2-(1-piperidinyl)ethenyl]- 0.0297837393005855 0.013835979
NSC 665522 Null 0.0297837393005855 0.14172511
NSC 732832 1-{2-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrol ylamino)phenylcarboxamido]ethyl}-3,4-dimethoxybenzene 0.0297837393005855 0.14435829
NSC 100880 Camptothecin 0.0297837393005856 0.64261984
NSC 244404 Null 0.0297837393005856 0.090510451
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0297837393005856 0.45294255
NSC 300289 Pinafide 0.0297837393005856 0.5351176
NSC 313681 Oxiperomide(USAN) 0.0297837393005856 -0.093515324
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0297837393005856 -0.063555752
Total:68  Current:42    [First] [Prev] [Next] [Last]